Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Johns Hopkins Genomics, |
RCV001007587 | SCV001167233 | uncertain significance | Autosomal dominant Alport syndrome | 2019-10-18 | criteria provided, single submitter | clinical testing | COL4A3 c.3644G>A has been reported in an individual with a clinical diagnosis of Alport syndrome, however, it has not been reported in ClinVar, to our knowledge. This variant (rs200443942) is present in a large population dataset5 (gnomAD: 35/253468 total alleles; 0.014%; no homozygotes). This missense substitution is located within the collagenous domain of COL4A3. Three bioinformatic tools queried predict that this substitution would be tolerated, and the arginine residue at this position is poorly evolutionarily conserved across the species assessed. Due to insufficient evidence, we consider the clinical significance of c.3644G>A to be uncertain at this time. |
Illumina Laboratory Services, |
RCV001141512 | SCV001301863 | uncertain significance | Alport syndrome | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. |
Center For Human Genetics And Laboratory Diagnostics, |
RCV001248769 | SCV001422278 | uncertain significance | Autosomal recessive Alport syndrome | 2019-03-15 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001702764 | SCV002072706 | uncertain significance | not provided | 2022-01-31 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; Occurs in the triple helical domain at the Y position in the canonical Gly-X-Y repeat; although this variant may have an effect on normal protein folding and function, missense substitution at the Y position is not a common mechanism of disease |
Invitae | RCV001702764 | SCV002479865 | likely benign | not provided | 2023-12-26 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001702764 | SCV001932056 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001702764 | SCV001974843 | likely benign | not provided | no assertion criteria provided | clinical testing |